Patent · US Active

Alpha-hemolysin variants

US11261488B2 · kind B2 · utility

0Cited by
3References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 30, 2020
Grant dateMar 1, 2022
Priority date—
Expiry dateJun 30, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N9/1241
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Described herein are engineered alpha-hemolysin subunits having mutated oligomerization domains for assembling into heptameric nanopores in lipid bilayers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.